Home Featured Page 252

Featured

Latest

mpathic Co-Founder Danielle Schlosser on AI Oversight of Psychedelics Trials

Patent Analysis: Lykos Suffers Blow from USPTO As All Patent Claims Stand Finally Rejected

Kama Flight: The Healing Power of Somatic Movement, Communication, and Trust

PsychedeliCare Launches First European Citizens’ Initiative Demanding Political Action on Psychedelic-Assisted Therapies

Pα+ Psychedelic Bulletin #185: Joe Rogan on Ibogaine; Wisconsin Medicaid to Cover IV Ketamine for Depression; Inside the Plan to Make Lykos MAPS Again

Numinus Wellness Inc. Announces $30 Million Bought Deal Public Offering

MINDCURE Names Tarik Lebbadi as Chief Operating Officer

Psychedelic Bulletin: Harvard Revisits Psychedelics; MindMed Attracts Strategic Investor; Psychedelics Companies...

Can Psilocybin Assisted Psychotherapy Change Attachment Style?

PTSF50 – Microdosing and the Placebo Effect, with Balázs Szigeti and...

Aion Therapeutic Files 4 New Patent Applications (Including for the Treatment...

Octarine Bio announces closing of extended seed round financing of $1.2...

BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using...

NeonMind Engages Certara to Advance its Synthetic Psilocybin Drug Candidates for...

DemeRx Receives MHRA Approval for DMX-1002 (Ibogaine) to Commence Phase 1/2a...

1...251252253...279 Page 252 of 279

mpathic Co-Founder Danielle Schlosser on AI Oversight of Psychedelics Trials

Patent Analysis: Lykos Suffers Blow from USPTO As All Patent Claims...

Kama Flight: The Healing Power of Somatic Movement, Communication, and Trust

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

mpathic Co-Founder Danielle Schlosser on AI Oversight of Psychedelics Trials

Patent Analysis: Lykos Suffers Blow from USPTO As All Patent Claims Stand Finally Rejected

Kama Flight: The Healing Power of Somatic Movement, Communication, and Trust

PsychedeliCare Launches First European Citizens’ Initiative Demanding Political Action on Psychedelic-Assisted Therapies

Pα+ Psychedelic Bulletin #185: Joe Rogan on Ibogaine; Wisconsin Medicaid to Cover IV Ketamine for Depression; Inside the Plan to Make Lykos MAPS Again

Numinus Wellness Inc. Announces $30 Million Bought Deal Public Offering

MINDCURE Names Tarik Lebbadi as Chief Operating Officer

Psychedelic Bulletin: Harvard Revisits Psychedelics; MindMed Attracts Strategic Investor; Psychedelics Companies...

Can Psilocybin Assisted Psychotherapy Change Attachment Style?

PTSF50 – Microdosing and the Placebo Effect, with Balázs Szigeti and...

Aion Therapeutic Files 4 New Patent Applications (Including for the Treatment...

Octarine Bio announces closing of extended seed round financing of $1.2...

BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using...

NeonMind Engages Certara to Advance its Synthetic Psilocybin Drug Candidates for...

DemeRx Receives MHRA Approval for DMX-1002 (Ibogaine) to Commence Phase 1/2a...

EDITOR PICKS

mpathic Co-Founder Danielle Schlosser on AI Oversight of Psychedelics Trials

Patent Analysis: Lykos Suffers Blow from USPTO As All Patent Claims...

Kama Flight: The Healing Power of Somatic Movement, Communication, and Trust

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY